▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2872 by analyst upside · 2026-09-28
ARDT
Ardent Health, Inc.
Healthcare · Market Cap $1B · P/E 19.5x
ANALYST PRICE TARGET
+20.2%
implied upside to consensus target
Current Price $10.54
Consensus Target $12.67
Bull Target $14.0
Bear Target $10.5
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
6
Hold
5
Sell
0
52-Week Low $7.71
52-Week High $15.48
YTD Return +22.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 19.5x
Forward P/E 8.4x
EPS (TTM) $0.54
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $6.4B
Profit Margin 1.2%
52-WEEK RANGE
52-Week Low $7.71
52-Week High $15.48
Current Price $10.54
Bear Target $10.5
Bull Target $14.0
● Now $10.54 ● Target $12.67
TRADING DATA
Avg Volume 462K
YTD Return +22.0%
Analyst Count 12
Consensus Buy
Upside to Target +20.2%
Last Updated 2026-09-28

ANALYST SUMMARY

Ardent Health, Inc. (ARDT) is currently trading at $10.54 with a Wall Street consensus price target of $12.67, implying potential upside of 20.2% over the next 12 months. 12 analysts currently cover ARDT, with a consensus rating of Buy - 58% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $10.5.

ARDT operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 22.0% year-to-date and is currently trading near the lower end of its 52-week range of $7.71 – $15.48.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PAHC +27.7%
Phibro Animal Health Corporation
$1B · P/E 14.2x · Hold
HCSG +28.3%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Buy
OMER +37.0%
Omeros Corporation
$1B · P/E 12.2x · Buy
CNMD +0.3%
CONMED Corporation
$1B · P/E 24.8x · Hold
AMN +4.6%
AMN Healthcare Services, Inc.
$1B · P/E 12.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ARDT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BMO Capital ● Initiated
Market Perform 2026-09-23 Building track record
Leerink Partners - Reiterated
Outperform → Outperform 2026-09-18 29% win rate (7 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-08-10 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-08-06 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-08-06 62% win rate (8 calls)
Truist Securities - Reiterated
Buy → Buy 2026-07-14 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-09 Building track record
UBS - Reiterated
Buy → Buy 2026-05-07 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
50
out of 100
Coverage depth
20/30
Consensus clarity
23/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →